Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Hackensack Meridian Health
University Hospital, Lille
Hackensack Meridian Health
National Cancer Institute (NCI)
University of Arkansas
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
University of Alabama at Birmingham
Stichting Hemato-Oncologie voor Volwassenen Nederland
City of Hope Medical Center
University of Turin, Italy
National Cancer Institute (NCI)
University of Chicago
Thomas Jefferson University
University of Iowa
SWOG Cancer Research Network
University of Arkansas
Weill Medical College of Cornell University
Washington University School of Medicine
Janssen Research & Development, LLC
University of Arkansas
University of Arkansas
University of Arkansas
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Emory University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Illinois at Chicago
Fondazione EMN Italy Onlus
Fondazione EMN Italy Onlus
Fondazione EMN Italy Onlus
Insel Gruppe AG, University Hospital Bern
CASI Pharmaceuticals (China) Co., Ltd.
University of Leeds
National Heart, Lung, and Blood Institute (NHLBI)
St. Petersburg State Pavlov Medical University
Janssen Research & Development, LLC
Case Comprehensive Cancer Center